Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$398M |
| 2 |
Apple
AAPL
|
+$326M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$286M |
| 4 |
UnitedHealth
UNH
|
+$267M |
| 5 |
Veralto
VLTO
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$730M |
| 2 |
Meta Platforms (Facebook)
META
|
+$674M |
| 3 |
Costco
COST
|
+$635M |
| 4 |
Amazon
AMZN
|
+$528M |
| 5 |
Expedia Group
EXPE
|
+$491M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29% |
| 2 | Healthcare | 13.85% |
| 3 | Consumer Discretionary | 11.46% |
| 4 | Financials | 11.04% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Adaptive Biotechnologies
ADPT
$3.57B
| $204K | ﹤0.01% |
43,930
-37,027
| -46% | -$169K |
|
1527
Cimpress
CMPR
$2.4B
| $202K | ﹤0.01% |
2,733
| – | – |
|
1528
The Greenbrier Companies
GBX
$1.56B
| $201K | ﹤0.01% |
4,307
+234
| +6% | +$9.15K |
|
|
CPRX
1529
DELISTED
Catalyst Pharmaceutical
CPRX
| $201K | ﹤0.01% |
13,159
+616
| +5% | +$8.42K |
|
1530
Beam Therapeutics
BEAM
$2.61B
| $200K | ﹤0.01% |
7,166
| – | – |
|
1531
Enerpac Tool Group
EPAC
$1.78B
| $199K | ﹤0.01% |
6,909
-271
| -4% | -$7.73K |
|
1532
Addus HomeCare
ADUS
$2.17B
| $199K | ﹤0.01% |
2,231
+200
| +10% | +$17.4K |
|
1533
Donnelley Financial Solutions
DFIN
$1.26B
| $198K | ﹤0.01% |
3,304
+139
| +4% | +$7.92K |
|
|
B
1534
DELISTED
Barnes Group Inc.
B
| $197K | ﹤0.01% |
6,547
+70
| +1% | +$2K |
|
1535
iRhythm Holdings
IRTC
$3.71B
| $197K | ﹤0.01% |
1,760
-316
| -15% | -$27.5K |
|
1536
Hope Bancorp
HOPE
$1.76B
| $195K | ﹤0.01% |
16,573
+1,345
| +9% | +$13.4K |
|
|
NVEI
1537
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $194K | ﹤0.01% |
7,882
-16,958
| -68% | -$326K |
|
1538
US Physical Therapy
USPH
$1.16B
| $194K | ﹤0.01% |
2,072
+204
| +11% | +$18K |
|
1539
Vita Coco
COCO
$3.86B
| $192K | ﹤0.01% |
+7,843
| New | +$213K |
|
|
ACH
1540
Accendra Health
ACH
$247M
| $192K | ﹤0.01% |
9,941
+403
| +4% | +$7.3K |
|
|
HBI
1541
DELISTED
Hanesbrands
HBI
| $192K | ﹤0.01% |
44,979
| – | – |
|
1542
MGP Ingredients
MGPI
$383M
| $192K | ﹤0.01% |
2,024
| – | – |
|
1543
Oxford Industries
OXM
$591M
| $191K | ﹤0.01% |
1,955
+89
| +5% | +$8.28K |
|
|
AMWD
1544
DELISTED
American Woodmark
AMWD
| $189K | ﹤0.01% |
2,118
+12
| +0.6% | +$935 |
|
|
HIBB
1545
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $188K | ﹤0.01% |
2,701
+286
| +12% | +$16K |
|
1546
FLEX LNG
FLNG
$1.64B
| $186K | ﹤0.01% |
6,126
+1,706
| +39% | +$51.2K |
|
1547
Horace Mann Educators
HMN
$2.1B
| $185K | ﹤0.01% |
5,653
+517
| +10% | +$16.6K |
|
|
IAUX
1548
i-80 Gold Corp
IAUX
$1.14B
| $185K | ﹤0.01% |
125,000
+25,000
| +25% | +$38.4K |
|
1549
Sally Beauty Holdings
SBH
$1.43B
| $183K | ﹤0.01% |
14,889
+1,303
| +10% | +$12.6K |
|
1550
AZZ Inc
AZZ
$4.43B
| $182K | ﹤0.01% |
3,191
| – | – |
|
Similar funds
Amundi's Q4 2023 Portfolio in Review
As of Q4 2023, Amundi held 2,118 positions worth $222B, up 9.2% from $203B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Amundi's Q4 2023 filing shows 107 new, 857 increased, 762 reduced and 120 closed positions. Its largest new stake was Veralto: 3,549,374 shares worth $276M. The largest sale was Wells Fargo 7.5% Non Cumv Perp Conv, an estimated $730M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amundi's largest Q4 2023 buy was Veralto: 3,549,374 shares worth $276M.
- Amundi added most to Johnson & Johnson in Q4 2023, an estimated $398M increase.
- Amundi's biggest Q4 2023 reduction was Wells Fargo 7.5% Non Cumv Perp Conv, cutting an estimated $730M.
- Amundi fully exited Activision Blizzard in Q4 2023, selling an estimated $284M.
- Amundi's ten largest holdings make up 23% of its $222B portfolio in Q4 2023.
- Amundi opened 107 new positions and closed 120 in Q4 2023.
- Amundi's portfolio value rose 9.2% quarter-over-quarter to $222B.
Based on Amundi's 13F filing for Q4 2023, filed 14 Feb 2024.